HR’s Crucial Role in Life Sciences IPOs

Sep 30, 2021

Guest blog by Julie Galvin, Senior Associate, WR Immigration

Much attention has been given to venture investments in New England life sciences companies. Private funding is creating an incredible lift for lab space, office space, hiring, and overall innovation.

IPOs, however, deserve as much recognition. Larger and fast-growing companies are heading for the Street, with nearly 50 U.S. biotech companies filing to go public in the first half of 2021. Those IPOs combined to raise nearly $9 billion (as of June 30, 2021).

The momentum is carrying forward from the record-breaking pace of 2020, however, it’s reasonable to expect this will slow at some point. A report by Silicon Valley Bank noted that post-IPO performance is lagging, which could lower the appetite for more biotechs and pharma on Wall Street. Regardless, activity in 2021 looks to be at least near the peak IPO numbers of 2020.

With IPOs come new shareholders to satisfy, analyst scrutiny, more rigorous reporting obligations, and a whole new business strategy. Every part of the organization has its work cut out for it, and human resources (HR) is no exception. As HR leaders plan pre- and post-IPO priorities for the workforce, they should:

Understand the impact on the overall workforce

IPOs can fundamentally change the direction and priorities of a company. While employees can be dazzled by the prospect of stock options and a quick boost in compensation, they sometimes miss the fine print about sacrifices that must be made in the name of a public listing.

HR teams should gather information about why the company is going public, how the effort is being supported, and what the vision is for the future.

For a great roadmap to IPO planning for HR, take a look at this content from the Society for Human Resources (SHRM), “Taming the Roller Coaster Ride of ‘Going Public.’”


Employees are often wary of dramatic change, and there is a high risk for a post-IPO shakeout. As employees get their arms around a new culture with different expectations, transparency is the best way to keep them engaged. If they can see where the train is headed, they are more likely to embrace the destination.

HR teams should develop a communications strategy that captures how life will be different after the IPO, and they should be ready for open dialogue about the future.

Develop a plan for turnover and foreign workers

Even with excellent strategy and communication initiatives in place, there will likely be turnover during or directly after an IPO. HR leaders in the life sciences must be ready with a recruiting plan to limit gaps in productivity and innovation.

Given the state of the talent market, that means attracting and retaining highly skilled foreign-born employees. HR should ask: which foreign-born employees are likely to leave? What countries have the right talent pool? What type of visas and talent will allow them to build the best workforce?

Understanding how foreign talent will contribute post-IPO will help companies stay ahead of talent shortages in critical areas. This is a sweet spot for us at WR Immigration, and we welcome any questions you might have.

IPOs can be an exciting path for Life Sciences companies – but they come with a fair share of stress for the entire organization. HR leaders should play an active role in conveying company direction and planning out the future for their workforce, including foreign-born employees.

About the Author:

Julie Galvin
Senior Associate, WR Immigration

Julie Galvin has extensive experience advising a wide variety of clients, ranging from non-profit organizations to multinational corporations, regarding all aspects of employment-based immigration, including nonimmigrant visa petitions, labor certification applications, preference-based immigrant visa petitions, and regulatory compliance.  She also advises musicians, scholars, and educational institutions, as well as families and individuals.

Julie gained over 10 years of experience as Immigration Counsel for a management-side employment law firm and as an Associate at a boutique immigration law firm, where she worked on employment-based and family-based immigration matters, as well as naturalization applications.

Julie earned her J.D. from the Washington College of Law at American University, located in Washington, D.C., where she served on the American University Law Review and was a student attorney in the International Human Rights Law Clinic, where she gained experience in asylum cases. She earned her B.A. from the University of Vermont, with a major in Philosophy and a minor in French. She is a member of the American Immigration Lawyers Association (AILA). She has spoken at the AILA New England Conference and MCLE and Boston Bar Association events. Outside the office, Julie enjoys reading, yoga, skiing, and spending time with her family.

See all MassBio News